🇺🇸 FDA
Patent

US 8716321

Methods for dosing an orally active 1,2,4-oxadiazole

granted A61KA61K31/4245A61K9/0053

Quick answer

US patent 8716321 (Methods for dosing an orally active 1,2,4-oxadiazole) held by PTC THERAPEUTICS, INC. expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/4245, A61K9/0053, A61K9/145, A61P